Propanc Biopharma said it will build a crypto treasury after securing up to $100 million from Hexstone Capital to further its potential cancer treatment and reignite investor interest.
Related Posts
BitMine’s Lee says Ether’s ‘price dislocation’ is a signal to buy

BitMine chairman Tom Lee said he expects Ethereum to enter a supercycle, making the current price an attractive risk vs reward purchase.
Bitcoin Slips Deeper Into Correction With Spot Demand Drying Up – What To Know
After losing the $80,000 price mark, the price of Bitcoin has made several attempts to recover this level, but each one was capped by this resistance zone, which was once a key support. Interestingly, this continued bearish pressure is beginning to reflect on multiple crucial areas of the market, such as Spot trading. Lack Of […]
Bitcoin Core Gets First-Ever Third-Party Security Audit: These Are The Results
Bitcoin Core, the reference implementation that underpins the majority of the BTC network, has undergone what Brink describes as the first-ever public, third-party security audit of its codebase. The assessment was carried out by security firm Quarkslab, coordinated by the Open Source Technology Improvement Fund (OSTIF) and funded by Brink with support from its donors. […]



